GlassScriptPhysician profile
Tyler J Smith
NPI 1316307754
$32,190.58
in general payments reported to CMS, 2019-2025
10 companies · $3,700 in 2025
The $3,700 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,358 · 2021: $3,600 · 2022: $10K · 2023: $2,323 · 2024: $8,892 · 2025: $3,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,638 · Consulting Fee: $5,625 · Food and Beverage: $2,652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,638.42 |
| Consulting Fee | $5,625.00 |
| Food and Beverage | $2,652.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,381.75 | 2022-2025 | |
| Liberty Surgical INC. | $6,958.02 | 2020-2021 | |
| Stryker Corporation | $5,914.04 | 2022-2025 | Inspace, Aequalis Perform Reversed, Variax |
| Novus Surgical Consultants | $5,351.47 | 2022-2025 | |
| Kairos Surgical INC | $3,884.38 | 2022 | |
| Novus Surgical Solutions LLC | $276.71 | 2022 | |
| Depuy Synthes Sales INC. | $133.57 | 2023-2024 | Rigidloop, Truespan Orthocord, Speedtrap |
| Vericel Corporation | $124.74 | 2024 | Maci |
| Linvatec Corporation | $97.53 | 2024 | Biobrace 23mm |
| Ermi LLC | $68.37 | 2024-2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.